Uncategorized

Homepage – Quiz Time 3/30

Which of the following suggests your patient is experiencing opioid-induced respiratory depression (OIRD)? a. Respiratory rate of 11 breaths/minute b. Pulse oximetry (Spo2) of…

FDA expands use of Xalkori

On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC) whose tumors…
The Future of Nursing

Nurses are nurses—unless they’re not

The key message of the Institute of Medicine’s (IOM) 2010 report “The Future of Nursing: Leading Change, Advancing Health” is that “nurses should achieve…

Homepage – Quiz Time 3/30

Which of the following suggests your patient is experiencing opioid-induced respiratory depression (OIRD)? a. Respiratory rate of 11 breaths/minute b. Pulse oximetry…

FDA expands use of Xalkori

On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC)…

Poll

Julie NyhusGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.